Low Purchasing Power Curtails Global Pharma Foray Into Myanmar
This article was originally published in PharmAsia News
Executive Summary
Myanmar is open for business, but prospects for a Thai-style boom in the ability to pay for drugs through reimbursement are more than a decade away. In the meantime, multinational firms begin the hard work of setting up from almost scratch.